23
Participants
Start Date
June 30, 2006
Primary Completion Date
November 30, 2010
Study Completion Date
January 31, 2012
Rituximab
Rituximab by slow intravenous infusion; for participants greater than or equal to 10 kg, 375 mg per m\^2 BSA weekly for 4 weeks; for participants less than 10 kg, 12.5 mg/kg weekly for 4 weeks
Hemophilia Center of Western Pennsylvania, Pittsburgh
Children's Hospital of Philadelphia, Philadelphia
UNC at Chapel Hill Hospital, Chapel Hill
Children's Healthcare of Atlanta, Atlanta
University Hospital of Cleveland, Cleveland
Comprehensive Center for Bleeding Disorders, Milwaukee
Rush University Medical Center, Chicago
Tulane University Health Sciences Center, New Orleans
University of Oklahoma Health Sciences Center, Oklahoma City
University of Texas Southwestern Medical Center, Dallas
Cook Children's Medical Center, Fort Worth
Children's Hospital of Orange County, Orange
Children's Hospital Boston, Boston
Lead Sponsor
Collaborators (1)
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Genentech, Inc.
INDUSTRY
Carelon Research
OTHER